Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of July 2025, with a specific reporting date of July 10, 2025. The document serves as a notification of transactions by Persons Discharging Managerial Responsibilities (PDMRs) in compliance with the UK Market Abuse Regulation. Haleon operates as a global leader in consumer health with a portfolio spanning oral health, vitamins, pain relief, respiratory health, digestive health, and therapeutic skin health.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider share transactions and does not contain financial performance data.
Material Changes and Transactions
The filing details two identical share transactions executed on July 9, 2025, on the London Stock Exchange (XLON) by senior executives under the Company's Share Reward Plan:
- Adrian Morris (General Counsel): Acquired 33 Partnership Shares at £3.701 per share and received 33 Matching Shares at no cost. Total aggregated volume: 66 shares.
- Tamara Rogers (Chief Marketing Officer): Acquired 33 Partnership Shares at £3.701 per share and received 33 Matching Shares at no cost. Total aggregated volume: 66 shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document is limited to the statutory disclosure of the aforementioned PDMR transactions.
Investor Verification Checklist
- Verify the total number of shares held by Adrian Morris and Tamara Rogers post-transaction to assess overall insider ownership concentration.
- Confirm the terms of the "Share Reward Plan" to understand the vesting schedule and conditions attached to the Partnership and Matching Shares.
- Review the market price of Haleon shares on July 9, 2025, to contextualize the £3.701 transaction price.
- Check for any subsequent filings regarding other PDMR transactions during the same period.